AU4218400A - Lyophilized solid dosage forms and methods of making - Google Patents

Lyophilized solid dosage forms and methods of making

Info

Publication number
AU4218400A
AU4218400A AU42184/00A AU4218400A AU4218400A AU 4218400 A AU4218400 A AU 4218400A AU 42184/00 A AU42184/00 A AU 42184/00A AU 4218400 A AU4218400 A AU 4218400A AU 4218400 A AU4218400 A AU 4218400A
Authority
AU
Australia
Prior art keywords
making
methods
dosage forms
solid dosage
lyophilized solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42184/00A
Inventor
Rajesh K. Agarwal
Kiran Chaudhary
Michael M. Goldberg
Shingai Majuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emisphere Technologies Inc
Original Assignee
Emisphere Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Technologies Inc filed Critical Emisphere Technologies Inc
Publication of AU4218400A publication Critical patent/AU4218400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU42184/00A 1999-04-05 2000-04-05 Lyophilized solid dosage forms and methods of making Abandoned AU4218400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12775499P 1999-04-05 1999-04-05
US60127754 1999-04-05
PCT/US2000/009412 WO2000059480A1 (en) 1999-04-05 2000-04-05 Lyophilized solid dosage forms and methods of making

Publications (1)

Publication Number Publication Date
AU4218400A true AU4218400A (en) 2000-10-23

Family

ID=22431779

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42184/00A Abandoned AU4218400A (en) 1999-04-05 2000-04-05 Lyophilized solid dosage forms and methods of making

Country Status (3)

Country Link
AU (1) AU4218400A (en)
WO (1) WO2000059480A1 (en)
ZA (2) ZA200309114B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610329B2 (en) 1993-04-22 2003-08-26 Emisphere Technologies Inc. Compositions for the delivery of antigens
AU2595697A (en) 1996-03-29 1997-10-22 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
TWI307279B (en) 2002-08-01 2009-03-11 Novartis Ag Oral administration of calcitonin
MXPA06013384A (en) 2004-05-19 2007-03-01 Emisphere Tech Inc Topical cromolyn formulations.
EP1750718B1 (en) 2004-05-19 2014-08-13 Emisphere Technologies, Inc. Acyclovir formulations
ES2535311T3 (en) 2004-12-29 2015-05-08 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US9364502B2 (en) 2006-06-28 2016-06-14 Emisphere Technologies, Inc. Gallium nitrate formulations
DE602008006700D1 (en) 2007-03-02 2011-06-16 Novartis Ag
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515001C2 (en) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Freeze-dried powders containing prostaglandin
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient

Also Published As

Publication number Publication date
WO2000059480A1 (en) 2000-10-12
ZA200107716B (en) 2003-08-18
ZA200309114B (en) 2005-02-23

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU5166500A (en) Interposer and method of making same
AU5611000A (en) Co-sintering of similar materials
AU3731600A (en) Composition and structures made therefrom
AU8007000A (en) Integrated forms and method of making such forms
AU4054900A (en) Desleucyl glycopeptide antibiotics and methods of making same
AU6555198A (en) Implanted structures and methods of formation
AU4652900A (en) Enabling and/or disabling selected types of broadcast triggers
AU7616300A (en) Refractory nzp-type structures and method of making and using same
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
IL135261A (en) Footwear and its method of construction
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU715620C (en) Therapeutic methods and uses
AU4218400A (en) Lyophilized solid dosage forms and methods of making
AU6920300A (en) Macrocyclic compounds and preparation methods thereof
AU2001246339A1 (en) Lyophilized powder of lentinan and the process of preparation thereof
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU1567301A (en) Tablets comprising micro-organisms and method for preparation of the tablets
AU1330301A (en) Canelo products and methods of making and using same
AU3476300A (en) Improved mouse and method of using
AU3793701A (en) Methods of identifying optimal drug combinations and compositions thereof
AU4176200A (en) Novel genetic suppressor elements and methods of making the same
AU4534000A (en) Molecular sieve desulfurizers and methods of making them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase